Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

7.96
Delayed Data
As of 2:37pm ET
 -0.09 / -1.12%
Today’s Change
2.73
Today|||52-Week Range
9.90
+50.76%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close8.05
Today’s open7.98
Day’s range7.88 - 8.04
Volume6,335
Average volume (3 months)171,861
Market cap$173.4M
Dividend yield--
Data as of 2:37pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)+4.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.44

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.03-2.27%
STDYSteadymed Ltd+0.02+0.63%
BLRXBioLine RX Ltd+0.05+4.59%
GLMDGalmed Pharmaceutica...-0.37-4.56%
Data as of 2:57pm ET, 10/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts